Outcomes of Surgical Myectomy and Mitral Valve Repair for Hypertrophic Cardiomyopathy With vs Without Marked Septal Hypertrophy
In patients with symptomatic HCM, even in those without marked septal hypertrophy, septal myectomy with a concomitant mitral valve apparatus intervention is safe and provides excellent relief of LVOT obstruction.
Authors
- Andrew Michael Crean (ORCID: https://orcid.org/0000-0002-2038-9178)
- Hanh D. Nguyen (ORCID: https://orcid.org/0000-0001-9707-3385)
- Menaka Ponnambalam (ORCID: https://orcid.org/0009-0009-4883-4665)
- Gyaandeo Maharajh (ORCID: https://orcid.org/0000-0003-1079-3481)
- Kenza Rahmouni (ORCID: https://orcid.org/0000-0003-3578-1305)
- Marc Ruel (ORCID: https://orcid.org/0000-0002-0487-1319)
- Sean Dickie (ORCID: https://orcid.org/0000-0002-8850-3045)
- Hugo Issa (ORCID: https://orcid.org/0000-0002-7068-890X)
- Juan B. Grau (ORCID: https://orcid.org/0000-0001-7604-1464)
- Omar Toubar
- Anne Williams (ORCID: https://orcid.org/0000-0003-1564-8574)
Institutions
- Memorial University of Newfoundland (CA)
- University of Ottawa (CA)
- Lebanon Valley College (US)
- Children's Hospital of Eastern Ontario (CA)
- Valley Hospital (US)
- McGill University (CA)
Publication Details
- Journal
- CJC Open
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1016/j.cjco.2025.04.007
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00